Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gary A. Lyons Other companies: Travere Therapeutics, Inc. (Director · Since at least Oct 8, 2014); Neurocrine Biosciences, Inc. (Director · Since at least May 25, 2010); Brickell Biotech Inc (Director · Feb 14, 2020 – May 17, 2022 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); NeurogesX Inc (Director · Apr 27, 2011 – Jun 7, 2012 · Past); Rigel Pharmaceuticals, Inc. (Director · May 28, 2010 – May 26, 2023 · Past); Vical Incorporated (Director · May 25, 2010 – May 23, 2018 · Past); Facet Biotech Corp (Director · Apr 20, 2010 – Apr 21, 2010 · Past) | Director · May 10, 2017 – May 1, 2023 · Past |
| Timothy J Barberich Other companies: TScan Therapeutics, Inc. (Director · Jul 15, 2021 – Dec 18, 2023 · Past); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Rocket Pharmaceuticals, Inc. (Director · Sep 28, 2016 – Jun 20, 2017 · Past); Verastem, Inc. (Director · Mar 10, 2014 – Jun 28, 2021 · Past); HeartWare International Inc (Director · Apr 29, 2008 – Aug 23, 2016 · Past); Biosphere Medical Inc (Director · May 10, 2006 – Sep 10, 2010 · Past); Sepracor Inc (Director · Mar 16, 2006 – Oct 20, 2009 · Past) | Director · Sep 16, 2014 – Jun 15, 2016 · Past |
| Keith A. Katkin Other companies: Emergent BioSolutions Inc. (Independent Director · Since at least Apr 1, 2022); Syndax Pharmaceuticals, Inc. (Director · Since at least Mar 29, 2017); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Sep 26, 2018 – Feb 19, 2020 · Past); Rigel Pharmaceuticals, Inc. (Director · Jun 29, 2015 – May 19, 2021 · Past); Carbylan Therapeutics Inc (Director · Apr 8, 2015 – Aug 3, 2015 · Past); Avanir Pharmaceuticals Inc (President and CEO, Director · May 15, 2013 – Dec 15, 2014 · Past) | Chairman of the Board of Directors · Since at least May 10, 2017 |
| James A Robinson Jr Other companies: UroGen Pharma Ltd. (Director · Since at least Jul 25, 2023); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Mar 1, 2019 – Mar 29, 2021 · Past); Neos Therapeutics Inc (Director · Jan 29, 2019 – Mar 19, 2021 · Past); Alkermes plc (President & COO,Alkermes, Inc. · Mar 5, 2018 – Apr 4, 2019 · Past) | Director · Since at least Oct 1, 2023 |
| Seth L. Harrison Other companies: Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Oct 20, 2015 · Past); HeartWare International Inc (Director · Jun 28, 2007 – Aug 23, 2016 · Past) | Director · Sep 16, 2014 – Jun 15, 2016 · Past |
| Christine Ocampo Other companies: Urovant Sciences Ltd (PAO; CAO/Urovant Sciences,Inc. · Sep 26, 2018 – Mar 29, 2021 · Past); Avanir Pharmaceuticals Inc (Vice President, Finance · Aug 11, 2010 – Dec 16, 2014 · Past) | See Remarks · May 10, 2017 – May 24, 2017 · Past |
| David-Alexandre C. Gros Other companies: Neurocrine Biosciences, Inc. (President & COO · Jan 9, 2017 – Feb 6, 2017 · Past); Alnylam Pharmaceuticals, Inc. (SVP, Chief Business Officer · Jun 8, 2015 – Dec 20, 2016 · Past) | CEO and Director · Since at least Sep 9, 2020 |
| Lee Kalowski Other companies: Q32 Bio Inc. (PRESIDENT & CHIEF FINANCIAL OFFICER · Since at least Mar 25, 2024); Bicycle Therapeutics PLC (President and CFO · May 22, 2019 – Apr 3, 2023 · Past) | Chief Financial Officer · Sep 16, 2014 – Dec 15, 2015 · Past |
| Bryan Smith Other companies: Urovant Sciences Ltd (GC/Urovant Sciences, Inc. · Sep 26, 2018 – Mar 29, 2021 · Past) | General Counsel · Since at least Apr 19, 2021 |
| Catherine C Turkel Other companies: Lexaria Bioscience Corp. (Director · Sep 2, 2022 – Aug 12, 2024 · Past) | President · May 20, 2019 – Mar 19, 2020 · Past |
| Gerald E Quirk Other companies: Syros Pharmaceuticals, Inc. (Chief Legal & Compliance Offic · Sep 26, 2016 – Nov 19, 2024 · Past) | General Counsel, Executive VP · May 26, 2015 – Dec 15, 2015 · Past |
| Jon Kuwahara Other companies: Emmaus Life Sciences, Inc. (Director · Oct 1, 2024 – Oct 1, 2024 · Past) | See Remarks · May 20, 2019 – Sep 11, 2020 · Past |
| June Lee Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Oct 18, 2024) | Director · Since at least Jan 10, 2025 |
| Stephen Buckley Jr Other companies: Enanta Pharmaceuticals, Inc. (Director · Mar 20, 2013 – Feb 28, 2019 · Past) | Director · Jan 8, 2015 – Jun 15, 2016 · Past |
| Allan Kirk | Director · Since at least Jul 17, 2025 |
| Carlos Candido | Vice President, Cell Therapy Operations · Since at least Nov 4, 2026 |
| David Hovland | Chief Regulatory Officer · Since at least Nov 4, 2026 |
| James Robinson | Director · Since at least Nov 5, 2026 |
| Jan Hillson | Director · Since at least Jan 10, 2026 |
| John Herberger | Vice President, Technical Operations · Since at least Nov 4, 2026 |
| John S. McBride | Director · Since at least Feb 1, 2022 |
| Marcela Laurito-Trammell | Vice President, Clinical Development – Transplantation · Since at least Nov 4, 2026 |
| Marina Escudero | Vice President, and Head of Clinical Operations · Since at least Nov 4, 2026 |
| Paul Little | Chief Financial Officer · Since at least Nov 4, 2026 |
| Sepideh Habibi | Vice President, and Head of Safety & Pharmacovigilance · Since at least Nov 4, 2026 |
| Steven Perrin | President, Director · Since at least Jul 31, 2026 |
| Steven Perrin | President and Chief Scientific Officer · Since at least Mar 4, 2026 |
| Yulan Li | Vice President, Biometrics · Since at least Nov 4, 2026 |